We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Mark Dempster

Mark Dempster

Co-Head Healthcare

Biopharma

New York

[email protected] | (212) 847-6491 | v-Card

Mark joined Stifel as a Managing Director in the Healthcare Investment Banking Group in connection with Stifel’s acquisition of Thomas Weisel Partners LLC in July 2010. Mark joined Thomas Weisel Partners in 2008 and is based in New York. Mark has served as the Co-Head of the Healthcare Investment Banking Group since 2017. Within the healthcare space, Mark focuses on the biotechnology and specialty pharmaceuticals subsectors.

Mark has over 25 years of experience in investment banking, including five years at Banc of America Securities, where he was a Principal in the Healthcare Investment Banking Group. Prior to Bank of America, Mark was a Vice President in the Mergers & Acquisitions group at JP Morgan Securities.

Mark has an MBA from the University of Michigan and a B.S. in Finance from Bradley University.